3rd HF Drug Discovery & Development Summit

3rd HF Drug Discovery & Development Summit banner

This 3rd HF Drug Discovery & Development Summit stands as the hub of knowledge, showcasing the latest in developments in the preclinical heart failure drug development. Together with 50+ experts, immerse yourself and your team in cutting edge cardiac drug development from discovery to target validation.

  • Elevate your understanding of precision approaches to heart failure with Bayer & Tenaya
  • Unearth developments in accelerating the translatability for heart failure disease modelling with Pfizer & Novo Nordisk
  • Stay ahead of the curve on developments in the intersection of aging biology and heart failure with Regeneron
  • Delve into novel biology from non-coding RNAs to gene therapy and small molecules with LEXEO, Cytokinetics & Cardior
  • Increase your understanding on optimal stratification of heart failure with Novartis
  • And so much more...

Get your copy of the 3-day agenda to discover more about the 18+ expert speakers, 20+ data-driven sessions and 10+ hours of networking.

12 April, 2024